These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3495054)

  • 1. Blocking of delivery of the antigen-mediated signal to the nucleus of T cells by cyclosporine.
    Hodgkin PD; Hapel AJ; Johnson RM; Young IG; Lafferty KJ
    Transplantation; 1987 May; 43(5):685-92. PubMed ID: 3495054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of action of Cyclosporin A: inhibition of lymphokine secretion studied with antigen-stimulated T cell hybridomas.
    Kaufmann Y; Chang AE; Robb RJ; Rosenberg SA
    J Immunol; 1984 Dec; 133(6):3107-11. PubMed ID: 6436374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence that cyclosporine inhibits cell-mediated immunity primarily at the level of the T lymphocyte rather than the accessory cell.
    Granelli-Piperno A; Keane M; Steinman RM
    Transplantation; 1988 Aug; 46(2 Suppl):53S-60S. PubMed ID: 3136567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of lymphokine release from T lymphoblasts. Requirement for mRNA synthesis and inhibition by cyclosporin A.
    Granelli-Piperno A; Inaba K; Steinman RM
    J Exp Med; 1984 Dec; 160(6):1792-802. PubMed ID: 6334715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T lymphocyte function in vivo. Ambivalence of the class I MHC antigen-reactive subset.
    Hodgkin PD; Agostino M; Sellins K; Prowse SJ; Bellgrau D; Lafferty KJ
    Transplantation; 1985 Sep; 40(3):288-92. PubMed ID: 3929437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of antigen-specific CD4+ effector T cells in vivo: immunization results in a transient population of MEL-14-, CD45RB- helper cells that secretes interleukin 2 (IL-2), IL-3, IL-4, and interferon gamma.
    Bradley LM; Duncan DD; Tonkonogy S; Swain SL
    J Exp Med; 1991 Sep; 174(3):547-59. PubMed ID: 1678774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency analysis of lymphokine-secreting CD4+ and CD8+ T cells activated in a graft-versus-host reaction.
    Kelso A
    J Immunol; 1990 Oct; 145(7):2167-76. PubMed ID: 1975827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vivo immunosuppressive action of suppressor cells from alloantigen-cyclosporine-treated mice and the capacity of spleen cells to release interleukins and gamma-interferon.
    Yoshimura N; Matsui S; Hamashima T; Kita M; Oka T
    Transplantation; 1988 Jan; 45(1):157-62. PubMed ID: 2962348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cyclosporin A on functions of specific murine T cell clones: inhibition of proliferation, lymphokine secretion and cytotoxicity.
    Weiss J; Schwinzer B; Kirchner H; Gemsa D; Resch K
    Immunobiology; 1986 Apr; 171(3):234-51. PubMed ID: 3086216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of lymphokine in islet allograft rejection.
    Hao LM; Wang Y; Gill RG; La Rosa FG; Talmage DW; Lafferty KJ
    Transplantation; 1990 Mar; 49(3):609-14. PubMed ID: 1969186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between up-regulation of lymphokine mRNA and down-regulation of TcR, CD4, CD8 and lck mRNA as shown by the effect of CsA on activated T lymphocytes.
    Paillard F; Sterkers G; Vaquero C
    Biochem Biophys Res Commun; 1992 Jul; 186(2):603-11. PubMed ID: 1497650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of cyclosporine A in vivo. II. T cell priming in vivo to alloantigen can be mediated by an IL-2-independent cyclosporine A-resistant pathway.
    Pereira GM; Miller JF; Shevach EM
    J Immunol; 1990 Mar; 144(6):2109-16. PubMed ID: 1968924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of lymphokine responsiveness of hapten-specific B lymphocytes promoted through an antigen-mediated T helper lymphocyte interaction.
    Krusemeier M; Snow EC
    J Immunol; 1988 Jan; 140(2):367-75. PubMed ID: 2447174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cyclosporine, cyclosporine metabolite 17, and other cyclosporine-related compounds on T lymphocyte clones derived from rejected human kidney grafts. I. Inhibition of proliferation.
    Chabannes D; Moreau JF; Soulillou JP
    Transplantation; 1987 Dec; 44(6):813-7. PubMed ID: 3321590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of lymphokine genes during stimulation of cloned T cells.
    Herold KC; Lancki DW; Dunn DE; Arai K; Fitch FW
    Eur J Immunol; 1986 Dec; 16(12):1533-8. PubMed ID: 3102245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of the immunosuppressive agents cyclosporine and leflunomide in vivo. Leflunomide blocks clonal T cell expansion yet allows production of lymphokines and manifestation of T cell-mediated shock.
    Lang R; Wagner H; Heeg K
    Transplantation; 1995 Feb; 59(3):382-9. PubMed ID: 7871569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphokine activity production in graft-versus-host reactions across minor histocompatibility antigen barriers.
    Hirokawa M; Takatsu H; Ohshima A; Chubachi A; Kudo K; Niitsu H; Takahashi T; Yoshida K; Miura AB
    Clin Exp Immunol; 1989 Sep; 77(3):434-9. PubMed ID: 2530013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.